Resistance Exercise for Osteoporosis
HS
DL
Overseen ByDonald Lein, PT, PhD
Age: 18+
Sex: Female
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: University of Alabama at Birmingham
No Placebo Group
Trial Summary
What is the purpose of this trial?
The aim of the 2 month randomized controlled trial is to investigate the feasibility of a novel progressive muscle resistance exercise in individuals with low bone mass.
Research Team
HS
HARSHVARDHAN SINGH, PT,PHD
Principal Investigator
University of Alabama at Birmingham
Eligibility Criteria
This trial is for postmenopausal women who can walk on their own and have been diagnosed with low bone mass. It's not suitable for those with secondary osteoporosis, uncontrolled high blood pressure, current non-zoledronic acid osteoporosis treatments, liver or kidney disease, unmanaged thyroid issues, recent cancer history, previous year resistance training, inability to walk independently or a fragility fracture.Inclusion Criteria
I have been diagnosed with low bone density.
I can walk by myself without help.
I can walk by myself without help.
Exclusion Criteria
Any other medical conditions which could restrict the potential participants from full participation as decided by their physician
You have done structured resistance training in the past year.
I have had cancer within the last 5 years.
See 8 more
Treatment Details
Interventions
- Novel Resistance Exercise (Behavioural Intervention)
Trial OverviewThe study tests a new muscle-strengthening exercise program over six months to see if it's doable for women with weak bones after menopause. Participants are randomly chosen to either join the exercise group or be in a control group without this specific training.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Exercise trainingExperimental Treatment1 Intervention
The exercise training group will receive progressive muscle resistive exercise, 10 sets of exercises for 2 times per week for a total of 6 months.
Group II: ControlActive Control1 Intervention
The control group will be asked to maintain their normal lifestyle and will be advised to continue their standard care of treatment.
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Alabama at Birmingham
Lead Sponsor
Trials
1,677
Recruited
2,458,000+